Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Lee JL"'
Autor:
Drakaki A; Division of Hematology and Oncology, UCLA David Geffen School of Medicine, Los Angeles, California., Powles T; Barts Cancer Centre, Barts Health NHS Trust, Queen Mary University of London, London, United Kingdom., Bamias A; National and Kapodistrian University of Athens, Athens, Greece., Martin-Liberal J; Medical Oncology Department, Catalan Institute of Oncology (ICO) Hospitalet, Barcelona, Spain., Shin SJ; Yonsei Cancer Center, Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea., Friedlander T; University of California San Francisco, Helen Diller Family Cancer Center, San Francisco, California., Tosi D; Institut régional du Cancer de Montpellier (ICM), Montpellier, France., Park C; Norton Cancer Institute, Louisville, Kentucky., Gomez-Roca C; Department of Medical Oncology, Institut Claudius Regaud/IUCT Oncopole, Toulouse, France., Joly Lobbedez F; Centre Francois-Baclesse, Medical Oncology, Caen, France., Castellano D; Hospital 12 de Octubre, Madrid, Spain., Morales-Barrera R; Vall d'Hebron Institute of Oncology, Vall d' Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain., Moreno-Candilejo I; START Madrid Phase I Unit, Hospital Sanchinarro, Madrid, Spain., Fléchon A; Centre Léon Bérard, Lyon, France., Yuen K; Genentech, Inc., South San Francisco, California., Rishipathak D; Genentech, Inc., South San Francisco, California., DuPree K; Genentech, Inc., South San Francisco, California., Young F; Roche Products Ltd, Welwyn Garden City, United Kingdom., Michielin F; Roche Innovation Center Basel, Basel, Switzerland., Shemesh CS; Genentech, Inc., South San Francisco, California., Steinberg EE; Genentech, Inc., South San Francisco, California., Williams P; Genentech, Inc., South San Francisco, California., Lee JL; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Nov 01; Vol. 29 (21), pp. 4373-4384.
Autor:
Rosenberg JE; Department of Medicine, Division of Solid Tumor Oncology, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, USA., Powles T; Department of Genitourinary Oncology, Barts Cancer Institute, CRUK Experimental Cancer Medicine Centre, London, UK., Sonpavde GP; Department of Bladder Cancer, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Loriot Y; Department of Renal Cancer, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Duran I; Department of Medical Oncology, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain., Lee JL; Department of Oncology, Urologic Cancer center, Asan Medical Center and University of Ulsan College of Medicine, Seoul, South Korea., Matsubara N; Department of Breast and Medical Oncology, National Cancer Center Hospital East, Chiba, Japan., Vulsteke C; Department of Molecular Imaging - Pathology - Radiotherapy - Oncology, Center for Oncological Research (CORE), University of Antwerp, Integrated Cancer Center Ghent, Ghent, Belgium., Castellano D; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Mamtani R; Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Wu C; Department of Biostatistics., Matsangou M; Department of Therapeutic Area-Oncology, Astellas Pharma, Inc., Northbrook., Campbell M; Department of Late Stage Development, Seagen Inc., Bothell., Petrylak DP; Department of Medicine and Urology, Yale Cancer Center, New Haven, USA. Electronic address: daniel.petrylak@yale.edu.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Nov; Vol. 34 (11), pp. 1047-1054. Date of Electronic Publication: 2023 Sep 09.
Autor:
Kim Y; Department of Cell and Genetic Engineering, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea., Ju H; Department of Cell and Genetic Engineering, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea., Yoo SY; Pathology Center, Seegene Medical Foundation, Seoul 04805, Korea., Jeong J; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea., Heo J; Department of Cell and Genetic Engineering, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea., Lee S; Department of Cell and Genetic Engineering, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea., Park JM; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea., Yoon SY; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea., Jeong SU; Department of Pathology, Ewha Womans University College of Medicine, Ewha Womans University Mokdong Hospital, Seoul 07985, Korea., Lee J; Department of Biochemistry and Molecular Biology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea., Yun H; Department of Cell and Genetic Engineering, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea., Ryu CM; Center for Cell Therapy, Asan Medical Center, Seoul 05505, Korea., Lee J; Department of Cell and Genetic Engineering, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea., Nam YJ; Department of Cell and Genetic Engineering, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea., Kwon H; Department of Cell and Genetic Engineering, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea., Son J; Department of Biochemistry and Molecular Biology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea., Jeong G; AI Recommendation, T3K, SK Telecom, Seoul 04539, Korea., Oh JH; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea., Sung CO; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea., Jeong EM; College of Pharmacy, Jeju National University, Jeju 63243, Korea., An J; Department of Public Health Sciences, Seoul National University, Seoul 08826, Korea; RexSoft, Inc., Seoul 08826, Korea., Won S; Department of Public Health Sciences, Seoul National University, Seoul 08826, Korea; RexSoft, Inc., Seoul 08826, Korea., Hong B; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea., Lee JL; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea. Electronic address: jaelyun@amc.seoul.kr., Cho YM; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea. Electronic address: yongcho@amc.seoul.kr., Shin DM; Department of Cell and Genetic Engineering, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea. Electronic address: d0shin03@amc.seoul.kr.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2023 Oct 17; Vol. 4 (10), pp. 101224. Date of Electronic Publication: 2023 Oct 04.
Autor:
Kim M; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul; Cancer Research Institute, Seoul National University College of Medicine, Seoul., Lee JL; Department of Oncology and Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul., Shin SJ; Division of Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul., Bae WK; Department of Hemato-Oncology, Chonnam National University Medical School & Hwasun Hospital, Hwasun., Lee HJ; Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon., Byun JH; Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon., Choi YJ; Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul., Youk J; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul; Cancer Research Institute, Seoul National University College of Medicine, Seoul., Ock CY; Lunit, Seoul, Republic of Korea., Kim S; Lunit, Seoul, Republic of Korea., Song H; Lunit, Seoul, Republic of Korea., Park KH; Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul., Keam B; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul; Cancer Research Institute, Seoul National University College of Medicine, Seoul. Electronic address: bhumsuk@snu.ac.kr.
Publikováno v:
ESMO open [ESMO Open] 2023 Aug; Vol. 8 (4), pp. 101588. Date of Electronic Publication: 2023 Jun 27.
Autor:
Lee JL; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Desai C; Department not applicable, Hemato-oncology Clinic (A) Pvt. Ltd., HOC Vedanta, Ahmedabad, India., Park SH; Department of Medicine, Sungkyunkwan University, Samsung Medical Center, Seoul, South Korea., Tsuchiya N; Department of Urology, Yamagata University Faculty of Medicine, Yamagata, Japan., Su PJ; Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Taoyuan City, Taiwan & College of Medicine, Chang Gung University, Taoyuan, Taiwan., Chan TTW; Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong., Gurney H; Department of Clinical Medicine, Macquarie University, Sydney, Australia., Gao S; Merck Pte. Ltd., Singapore, an affiliate of Merck KGaA, Darmstadt, Germany., Wang J; Pfizer, Cambridge, MA., Sandner R; Pfizer, Collegeville, PA., di Pietro A; Pfizer srl, Milano, Italy., Eto M; Department of Urology, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan. Electronic address: eto.masatoshi.717@m.kyushu-u.ac.jp.
Publikováno v:
Urologic oncology [Urol Oncol] 2023 May; Vol. 41 (5), pp. 256.e17-256.e25. Date of Electronic Publication: 2023 Apr 03.
Autor:
Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Medicine, Sandra and Edward Meyer Cancer Center, New York, NY., Petrylak DP; Yale Cancer Center, New Haven, CT., Bellmunt J; Beth Israel Deaconess Medical Center and PSMAR-IMIM Lab, Boston, MA.; Harvard Medical School, Boston, MA., Nishiyama H; Department of Urology, University of Tsukuba, Tsukuba, Japan., Necchi A; Vita-Salute San Raffaele University and IRCCS San Raffaele Hospital and Scientific Institute, Milan, Italy., Gurney H; Clinical Trials Unit FMHS, Macquarie University, Sydney, New South Wales, Australia., Lee JL; University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea., van der Heijden MS; Medical Oncology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Rosenbaum E; Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel., Penel N; Lille University and Department of Medical Oncology, Centre Oscar Lambret, Lille, France., Pang ST; Division of Urology, Department of Surgery, Linkou Chang Gung Memorial Hospital, Linkou, Taiwan., Li JR; Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan., García Del Muro X; Department of Medical Oncology, University of Barcelona, Idibell Institute of Research, Institut Català d'Oncologia Hospitalet, Barcelona, Spain., Joly F; Clinical Research Department, Centre François Baclesse, Caen, France., Pápai Z; Oncology Department, Medical Centre, Hungarian Defence Forces, Budapest, Hungary., Bao W; Bayer HealthCare Pharmaceuticals, Inc, Whippany, NJ., Ellinghaus P; Bayer AG, Wuppertal, Germany., Lu C; Bayer HealthCare Pharmaceuticals, Inc, Whippany, NJ., Sierecki M; Bayer HealthCare Pharmaceuticals, Inc, Whippany, NJ., Coppieters S; Bayer AG, Diegem, Belgium., Nakajima K; Bayer HealthCare Pharmaceuticals, Inc, Whippany, NJ., Ishida TC; Bayer HealthCare Pharmaceuticals, Inc, Whippany, NJ., Quinn DI; Division of Oncology, Department of Medicine, USC Norris Comprehensive Cancer Center, Los Angeles, CA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jan 20; Vol. 41 (3), pp. 629-639. Date of Electronic Publication: 2022 Oct 14.
Autor:
Eto M; Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Lee JL; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Chang YH; Taipei Veterans General Hospital, Taipei, Taiwan., Gao S; Merck Pte. Ltd., Singapore, an affiliate of Merck KGaA., Singh M; Pfizer Corporation Hong Kong Ltd., Hong Kong., Gurney H; Department of Clinical Medicine, Macquarie University, Sydney, New South Wales, Australia.
Publikováno v:
Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2022 Oct; Vol. 18 (5), pp. e191-e203. Date of Electronic Publication: 2022 Mar 03.
Autor:
Yoon S; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Shin SJ; Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea., Kim HC; Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Kim YS; Division of Medical Oncology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea., Lee HJ; Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Republic of Korea., Keam B; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea., Choi YJ; Division of Hematology-Oncology, Department of Medicine, Korea University Anam Hospital, Seoul, Republic of Korea., Kim YJ; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea., Park I; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; Division of Medical Oncology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea., Park SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Lee JL; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address: jaelyun@amc.seoul.kr.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Oct; Vol. 174, pp. 81-89. Date of Electronic Publication: 2022 Aug 16.
Autor:
Hwang I; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.; Department of Oncology, Yuseong Sun Medical Center, Daejeon, South Korea., Park I; Division of Medical Oncology, Department of Internal Medicine, Gil Medical Center, Gachon University School of Medicine, Incheon, Korea., Yoon SK; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Lee JL; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Publikováno v:
Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2022 Aug; Vol. 18 (4), pp. 371-377. Date of Electronic Publication: 2021 Jul 05.
Autor:
de Wit R; Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Powles T; Barts Cancer Institute, Queen Mary University of London, UK., Castellano D; Hospital 12 de Octubre, I + 12 Research Institute, Madrid, Spain., Necchi A; Vita-Salute San Raffaele University, IRCCS San Raffaele Hospital, Milan, Italy., Lee JL; Asan Medical Centre, University of Ulsan College of Medicine, Seoul, Republic of Korea., van der Heijden MS; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Matsubara N; National Cancer Center Hospital East, Chiba, Japan., Bamias A; National and Kapodistrian University of Athens, Athens, Greece., Fléchon A; Centre Léon Bérard, Lyon, France., Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Medicine, Sandra and Edward Meyer Cancer Center, New York, NY, USA., Drakaki A; University of California Los Angeles, Los Angeles, CA, USA., Yu EY; University of Washington and Fred Hutchinson Cancer Center, Seattle, WA, USA., Zimmermann AH; Eli Lilly and Company, Indianapolis, IN, USA., Long A; Eli Lilly and Company, Indianapolis, IN, USA., Walgren RA; Eli Lilly and Company, Indianapolis, IN, USA., Gao L; Eli Lilly and Company, Indianapolis, IN, USA., Bell-McGuinn KM; Eli Lilly and Company, Indianapolis, IN, USA., Petrylak DP; Yale University School of Medicine, New Haven, CT, USA.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2022 Jul; Vol. 88 (7), pp. 3182-3192. Date of Electronic Publication: 2022 Feb 07.